Cargando…
The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus
BACKGROUND: Fibrocalculous pancreatic diabetes (FCPD) is a secondary form of diabetes, described from several tropical countries, including India. We described the existence of this entity in the subtropical region-the Kashmir valley of the Indian subcontinent and compared the clinical characteristi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873263/ https://www.ncbi.nlm.nih.gov/pubmed/31803601 http://dx.doi.org/10.4103/ijem.IJEM_297_19 |
_version_ | 1783472631562895360 |
---|---|
author | Bhat, Javaid Ahmad Bhat, Moomin Hussain Misgar, Raiz Ahmad Bashir, Mir Iftikhar Wani, Arshad Iqbal Masoodi, Shariq Rashid Ashraf, Hamid Sood, Mona |
author_facet | Bhat, Javaid Ahmad Bhat, Moomin Hussain Misgar, Raiz Ahmad Bashir, Mir Iftikhar Wani, Arshad Iqbal Masoodi, Shariq Rashid Ashraf, Hamid Sood, Mona |
author_sort | Bhat, Javaid Ahmad |
collection | PubMed |
description | BACKGROUND: Fibrocalculous pancreatic diabetes (FCPD) is a secondary form of diabetes, described from several tropical countries, including India. We described the existence of this entity in the subtropical region-the Kashmir valley of the Indian subcontinent and compared the clinical characteristics of these patients with type 2 diabetes mellitus (T2DM) patients. AIM: The present study aimed to compare the clinical characteristics of patients with FCPD and those with T2DM to identify the characteristics distinctive of FCPD. MATERIALS AND METHODS: A total of 124 patients with FCPD were compared with 124 patients with T2DM matched for age and duration of diabetes. Biochemical parameters and microvascular and macrovascular complications were assessed in all patients. Multivariate regression analyses were performed to study the determinants of microvascular complications in both groups. RESULTS: FCPD patients had significantly lower serum cholesterol, serum triglyceride, and serum calcium levels but higher glycosylated hemoglobin levels compared to T2DM patients. FCPD participants were significantly leaner. The prevalence of retinopathy, neuropathy, and nephropathy was similar between the two. Five T2DM patients had documented cardiovascular disease compared to one in FCPD patients (P < 0.05). Multiple logistic regression analysis revealed glycosylated hemoglobin and duration of diabetes to be significantly associated with retinopathy and nephropathy in T2DM. Among FCPD patients, glycosylated hemoglobin showed a strong association with retinopathy as well as nephropathy. BMI showed a significant negative association with nephropathy in FCPD patients. Age and age at onset showed a strong association with neuropathy in FCPD patients while the duration of diabetes showed the association with neuropathy (P = 0.015) in T2DM. CONCLUSION: There are several differences in the phenotype, biochemical parameters, and prevalence of diabetic complications between patients with FCPD and T2DM. |
format | Online Article Text |
id | pubmed-6873263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-68732632019-12-04 The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus Bhat, Javaid Ahmad Bhat, Moomin Hussain Misgar, Raiz Ahmad Bashir, Mir Iftikhar Wani, Arshad Iqbal Masoodi, Shariq Rashid Ashraf, Hamid Sood, Mona Indian J Endocrinol Metab Original Article BACKGROUND: Fibrocalculous pancreatic diabetes (FCPD) is a secondary form of diabetes, described from several tropical countries, including India. We described the existence of this entity in the subtropical region-the Kashmir valley of the Indian subcontinent and compared the clinical characteristics of these patients with type 2 diabetes mellitus (T2DM) patients. AIM: The present study aimed to compare the clinical characteristics of patients with FCPD and those with T2DM to identify the characteristics distinctive of FCPD. MATERIALS AND METHODS: A total of 124 patients with FCPD were compared with 124 patients with T2DM matched for age and duration of diabetes. Biochemical parameters and microvascular and macrovascular complications were assessed in all patients. Multivariate regression analyses were performed to study the determinants of microvascular complications in both groups. RESULTS: FCPD patients had significantly lower serum cholesterol, serum triglyceride, and serum calcium levels but higher glycosylated hemoglobin levels compared to T2DM patients. FCPD participants were significantly leaner. The prevalence of retinopathy, neuropathy, and nephropathy was similar between the two. Five T2DM patients had documented cardiovascular disease compared to one in FCPD patients (P < 0.05). Multiple logistic regression analysis revealed glycosylated hemoglobin and duration of diabetes to be significantly associated with retinopathy and nephropathy in T2DM. Among FCPD patients, glycosylated hemoglobin showed a strong association with retinopathy as well as nephropathy. BMI showed a significant negative association with nephropathy in FCPD patients. Age and age at onset showed a strong association with neuropathy in FCPD patients while the duration of diabetes showed the association with neuropathy (P = 0.015) in T2DM. CONCLUSION: There are several differences in the phenotype, biochemical parameters, and prevalence of diabetic complications between patients with FCPD and T2DM. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6873263/ /pubmed/31803601 http://dx.doi.org/10.4103/ijem.IJEM_297_19 Text en Copyright: © 2019 Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Bhat, Javaid Ahmad Bhat, Moomin Hussain Misgar, Raiz Ahmad Bashir, Mir Iftikhar Wani, Arshad Iqbal Masoodi, Shariq Rashid Ashraf, Hamid Sood, Mona The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus |
title | The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus |
title_full | The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus |
title_fullStr | The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus |
title_full_unstemmed | The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus |
title_short | The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus |
title_sort | clinical spectrum of fibrocalculous pancreatic diabetes in kashmir valley and comparative study of the clinical profile of fibrocalculous pancreatic diabetes and type 2 diabetes mellitus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873263/ https://www.ncbi.nlm.nih.gov/pubmed/31803601 http://dx.doi.org/10.4103/ijem.IJEM_297_19 |
work_keys_str_mv | AT bhatjavaidahmad theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT bhatmoominhussain theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT misgarraizahmad theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT bashirmiriftikhar theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT waniarshadiqbal theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT masoodishariqrashid theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT ashrafhamid theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT soodmona theclinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT bhatjavaidahmad clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT bhatmoominhussain clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT misgarraizahmad clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT bashirmiriftikhar clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT waniarshadiqbal clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT masoodishariqrashid clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT ashrafhamid clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus AT soodmona clinicalspectrumoffibrocalculouspancreaticdiabetesinkashmirvalleyandcomparativestudyoftheclinicalprofileoffibrocalculouspancreaticdiabetesandtype2diabetesmellitus |